Jefferies Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7.25M | Hold |
165,700
| – | – | 0.06% | 265 |
|
|
2022
Q2 | $8.69M | Buy |
165,700
+115,700
| +231% | +$5.9M | 0.07% | 221 |
|
|
2022
Q1 | $2.59M | Sell |
50,000
-366,600
| -88% | -$19M | 0.02% | 604 |
|
|
2021
Q4 | $24.6M | Buy |
416,600
+311,400
| +296% | +$15.4M | 0.14% | 114 |
|
|
2021
Q3 | $4.52M | Buy |
+105,200
| New | +$4.66M | 0.03% | 469 |
|
|
2021
Q1 | – | Sell |
-362,300
| Closed | -$13.3M | – | 1899 |
|
|
2020
Q4 | $13.3M | Buy |
362,300
+18,274
| +5% | +$670K | 0.1% | 164 |
|
|
2020
Q3 | $12M | Buy |
344,026
+177,178
| +106% | +$6.21M | 0.13% | 116 |
|
|
2020
Q2 | $5.18K | Sell |
166,848
-285,213
| -63% | -$9.69M | 0.06% | 267 |
|
|
2020
Q1 | $14M | Buy |
452,061
+182,764
| +68% | +$6.23M | 0.16% | 97 |
|
|
2019
Q4 | $10M | Sell |
269,297
-442,469
| -62% | -$15.8M | 0.08% | 227 |
|
|
2019
Q3 | $24.3M | Buy |
711,766
+254,541
| +56% | +$9.26M | 0.19% | 66 |
|
|
2019
Q2 | $18.8M | Sell |
457,225
-229,456
| -33% | -$9.11M | 0.14% | 111 |
|
|
2019
Q1 | $27.7M | Buy |
686,681
+439,413
| +178% | +$17.6M | 0.23% | 49 |
|
|
2018
Q4 | $10.2M | Sell |
247,268
-579,173
| -70% | -$24M | 0.08% | 193 |
|
|
2018
Q3 | $34.6M | Buy |
826,441
+481,045
| +139% | +$18.5M | 0.23% | 63 |
|
|
2018
Q2 | $11.9M | Sell |
345,396
-654,007
| -65% | -$22.3M | 0.07% | 223 |
|
|
2018
Q1 | $33.7M | Buy |
999,403
+663,388
| +197% | +$22.8M | 0.18% | 65 |
|
|
2017
Q4 | $11.5M | Sell |
336,015
-254,752
| -43% | -$8.69M | 0.05% | 263 |
|
|
2017
Q3 | $20M | Buy |
590,767
+299,125
| +103% | +$9.61M | 0.13% | 123 |
|
|
2017
Q2 | $9.29M | Sell |
291,642
-76,942
| -21% | -$2.43M | 0.06% | 296 |
|
|
2017
Q1 | $12M | Sell |
368,584
-1,020,693
| -73% | -$32.2M | 0.09% | 215 |
|
|
2016
Q4 | $42.8M | Buy |
1,389,277
+105,505
| +8% | +$3.22M | 0.24% | 54 |
|
|
2016
Q3 | $41.3M | Sell |
1,283,772
-1,890,244
| -60% | -$63.2M | 0.21% | 73 |
|
|
2016
Q2 | $106M | Buy |
3,174,016
+1,888,031
| +147% | +$60.3M | 0.48% | 23 |
|
|
2016
Q1 | $36.2M | Buy |
1,285,985
+333,801
| +35% | +$9.53M | 0.21% | 65 |
|
|
2015
Q4 | $29.2M | Sell |
952,184
-1,367,459
| -59% | -$43M | 0.17% | 107 |
|
|
2015
Q3 | $69.1M | Sell |
2,319,643
-381,548
| -14% | -$12.2M | 0.4% | 38 |
|
|
2015
Q2 | $85.9M | Buy |
2,701,191
+1,002,775
| +59% | +$32.7M | 0.44% | 30 |
|
|
2015
Q1 | $56.1M | Buy |
1,698,416
+102,765
| +6% | +$3.27M | 0.31% | 44 |
|
|
2014
Q4 | $47.2M | Buy |
1,595,651
+289,850
| +22% | +$8.31M | 0.28% | 71 |
|
|
2014
Q3 | $36.6M | Buy |
1,305,801
+380,389
| +41% | +$10.7M | 0.25% | 71 |
|
|
2014
Q2 | $26.1M | Buy |
925,412
+4,216
| +0.5% | +$120K | 0.22% | 84 |
|
|
2014
Q1 | $28.1M | Buy |
+921,196
| New | +$27.5M | 0.27% | 62 |
|
|
2013
Q3 | – | Sell |
-536,275
| Closed | -$14.3M | – | 2134 |
|
|
2013
Q2 | $14.3M | Buy |
+536,275
| New | +$14.8M | 0.15% | 99 |
|
Other funds holding PFE
Jefferies Group's PFE Position: Q3 2022 in Review
Jefferies Group increased its Pfizer (PFE) stake by 45% in Q3 2022, buying an estimated $3.42M and bringing the position to 224,984 shares worth $9.85M. The position accounts for 0.08% of the portfolio, ranked #192.
Jefferies Group first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $56.6M in Q4 2015. 3,085 funds tracked by Wall St. Rank hold PFE as of Q3 2022.
- Jefferies Group held 224,984 shares of Pfizer worth $9.85M as of Q3 2022.
- Jefferies Group bought 70,327 Pfizer shares in Q3 2022, an estimated $3.42M.
- Pfizer made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #192 holding.
- Jefferies Group first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
- Jefferies Group's Pfizer position peaked at $56.6M in Q4 2015.
- 3,085 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.